ArticleCureus2025
Hepatic Angiosarcoma Mimicking Sinusoidal Obstruction Syndrome: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic angiosarcoma (HAS) is an uncommon malignant tumor that is often misdiagnosed because of its nonspecific presentation and overlapping imaging findings with benign vascular tumors. Sinusoidal obstruction syndrome (SOS) is a disorder of hepatic microcirculation, usually associated with myeloablative chemotherapy and hematopoietic stem cell transplantation. The clinical and pathological overlap between SOS and hepatic angiosarcoma may complicate the diagnosis of hepatic angiosarcoma, as illustrated by this case. We report the case of a sixty-year-old man who presented to the emergency department with progressive jaundice, abdominal discomfort, and weight loss exceeding 5% of his baseline. Laboratory workup revealed a predominantly cholestatic pattern, and serologies for viral, autoimmune, and metabolic liver diseases were negative. Also, there were no known risk factors for liver disease or SOS. Repeated imaging studies, including computed tomography (CT) and magnetic resonance imaging (MRI), revealed a large vascular hepatic lesion, suggestive of a benign lesion, and Doppler revealed findings compatible with SOS. Liver biopsy and hemodynamic studies indicated hepatic outflow obstruction. After clinical deterioration and expert multidisciplinary review of imaging and histology, malignant endothelial proliferation consistent with hepatic angiosarcoma was identified. Hepatic angiosarcoma can closely mimic SOS morphologically and hemodynamically. The absence of identifiable risk factors and the progressive evolution of hepatic changes should raise suspicion of malignancy, prompting multidisciplinary reassessment and careful histologic review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.